3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Triple Negative Breast Neoplasms
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
Cytarabine
147
Azacitidine
100
venetoclax
95
Cyclophosphamide
70
fludarabine
69
Decitabine
63
fludarabine phosphate
55
Specimen Handling
37
Filgrastim
35
Daunorubicin
35
Mitoxantrone
30
Idarubicin
29
Etoposide
27
Biopsy
26
Injections
25
Granulocyte Colony-Stimulating Factor
25
Busulfan
22
Tacrolimus
21
Clofarabine
21
Mycophenolic Acid
18
Melphalan
18
Methotrexate
17
Bortezomib
17
Whole-Body Irradiation
16
Stem Cell Transplantation
16
Peripheral Blood Stem Cell Transplantation
16
Vorinostat
15
Gemtuzumab
15
Lenalidomide
14
decitabine and cedazuridine drug combination
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Leukemia, Myeloid, Acute
×
Immunotherapy, Active
×
Clear all
NCT07551037
2026-05-01
AML
Fujian Medical University Union Hospital
Phase 1
Recruiting
90 enrolled